Cardiovascular changes
Arterial compliance
Loss of arterial compliance, increase in SVR, LVH, diastolic dysfunction, hypertension
Venous compliance
Loss of venous compliance
Cardiac output
Resting cardiac output-normal, diminished ability to increase stroke volume, preload important
Pacemaker cells
Decreased, conduction abnormalities
Beta-adrenergic response
Diminished response, decrease in maximal heart rate
Pulmonary changes
No change
Functional residual capacity, PaCO2
Increase
Residual volume, closing capacity, dead space, work of breathing, VQ mismatch
Decrease
PaO2, FEV1, HPV, thoracic wall compliance, alveolar elasticity, vital capacity, total lung capacity, maximum breathing capacity
Changes in Cardiac Conduction System
The conduction system gradually undergoes fibrosis predisposing to atrial fibrillation, sick sinus syndrome, and heart block. Atrial fibrillation is the commonest clinically significant rhythm disorder affecting about 6 % of patients older than 65 years and 12 % of patients above 85 years in the United States. As the conduction defect is anatomical and the rhythm disorder is permanent, perioperatively rate control overscores the need of rhythm control in elderly patients.
Changes in Cardiac Autonomic Innervation
Autonomic tissue is progressively replaced with connective tissue producing a relative “hyposympathetic state,” impairing cardiac ability to augment output via increased chronotropy and inotropy. Perioperatively these patients, thus primarily, depend upon adequate preload to raise their cardiac output whenever needed. The relative denervation leads to receptor upregulation and associated conduction system defects, predisposing elderly patients to increased arrhythmogenic potential of autonomic drugs. Impaired autonomic efferents along with age-related arteriosclerosis impair adequate baroreceptor responses in elderly, increasing the propensity for uncompensated hypotension to induction agents and acute blood loss under anesthesia.
Changes in Vascular System
Aging of the vasculature results in increased arterial thickening and endothelial dysfunction. These changes cause increased systolic blood pressure (pressure > 180 mmHg) and pulse pressures, pulmonary hypertension, and present as risk factors for atherosclerosis, coronary artery disease, and stroke.
Respiratory System
Available evidence suggests that even after adjusting for comorbidities, aging remains a significant factor accounting for postoperative pulmonary complications in the elderly. Compared to patients younger than 60 years, patients between 60 and 69 years are twice and patients between 70 and 79 years are thrice as likely to develop postsurgical pulmonary complications.
Changes in Anatomy and Mechanics of Breathing System
Loss of laryngopharyngeal muscle mass and coordination predispose elderly patients to perioperative airway collapse and pulmonary aspiration, respectively. Decline in lung function is primarily contributed by loss of lung elasticity, increasing chest wall stiffness, and reduced inspiratory muscle strength (Table 43.1). Small airway collapsibility causes air trapping, which leads to “senile emphysema.” However, this must be distinguished from actual emphysema in the preoperative evaluation, as the total lung capacity is decreased significantly in the latter.
Basal hyperinflation leads to flattening of the diaphragm, which accompanied by weaker chest muscles has major consequences. The vital capacity is decreased; hence ‘4-vital capacity breaths’ for preoxygenation in an elderly patient may not be effective. The already compromised thoracic muscles are highly susceptible to postoperative residual weakness with the use of nondepolarizing neuromuscular blockers. A flattened diaphragm not only makes respiration abdominothoracic, but significantly increases the work of breathing, leading to difficult weaning and extubation of these patients. Other notable changes include fall of FEV1 (6–8 % per decade), increased closing capacity, and residual volume. The closing capacity (volume of air in the lungs at which small airways begin to close) exceeds the functional residual capacity (volume of air remaining in the lungs at the end of a normal expiration) at age 45 years in the supine position, and at age 65 years in the sitting position.
Changes in Diffusion Properties
Uneven distribution of ventilation, increased closing capacity, and increased thickness of the interstitial barrier account for age-related fall in diffusion capacity. With age, arterial oxygen tension falls by 0.3–0.4 mmHg yearly; however, the partial pressure of CO2 remains almost constant due to decreased production and much higher diffusion capacity of CO2. This predisposes the elderly patient to desaturation under anesthesia. Positive pressure ventilation extends West’s Zone I (see Chap. 28), which increases dead space ventilation.
Changes in Central Respiratory Drive and Sensitivity
As a result of decreased peripheral and central chemoreceptor sensitivity with age, the ventilatory drive in response to hypoxia and hypercarbia falls by about 50 % and 40 %, respectively. This becomes even more significant in the perioperative period, where drugs like opioids and benzodiazepines further suppress these ventilatory responses, preventing compensatory responses to desaturation, with resultant CO2 retention.
Renal System
Postoperative renal failure accounts for up to 25–50 % of etiologies of acute renal failure in the elderly. This renal injury is often iatrogenic and preventable, and thus, is a significant modifiable factor in improving the outcome of surgery in the elderly.
Changes in Glomerular Function
Renal function is commonly determined by the glomerular filtration rate (GFR) and serum creatinine. The average age-related loss in GFR is 6–8 % per decade. By the age of 80 years, the number of glomeruli is reduced to half than that at age 30 years, causing increased rate of sclerosis of the residual hyperfunctioning nephrons. As the body muscle mass also decreases, the deteriorating renal function may not be reflected by measurements of serum creatinine (measuring creatinine clearance reflects renal function better). However, the decrease in GFR tends to prolong the half-life of the anesthetic drugs which are primarily dependent upon glomerular clearance. Newer tests with molecules like cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule 1 (KIM-1), which remain unaffected by age, may serve better in measuring perioperative renal function.
Changes in Tubular Function
The ability to conserve sodium and excrete H+ decreases with aging, diminishing the ability to regulate fluids and acid-base balance. Decreased sensitivity to renin-angiotensin and ADH impairs renal ability to compensate for perioperative hypervolemia and extra renal fluid losses. The susceptibly to fluid overload also increases, due to the inability to excrete excess fluids as a result of decreased GFR.
Changes in the Urinary Tract
Urinary retention and catheter sensation are typically common problems in the elderly, which are aggravated by the use of opioids. Prostatic hyperplasia in elderly males and decreased estrogen levels in females alter urinary sphincter tone leading to urinary retention, thus promoting urinary tract infections and predisposing the patients to perioperative bacteremia.
Hepatobiliary and Gastrointestinal System
Anesthesia can be considered as a pharmacological interplay between the drugs metabolized by the liver, with age-related changes making significant alterations to both the pharmacokinetics and pharmacodynamics.
Changes in Hepatobiliary System
Liver blood flow and size both decrease by around 35 % in old age. Any hypotension causing a further decrease in hepatic blood flow can significantly prolong drug action. Phase I metabolic reactions (cytochrome p450 enzyme-based reactions) are prolonged, whereas phase II reactions (conjugation reactions) are well preserved, which may guide the anesthesiologists’ choice to use drugs metabolized via phase II reactions in the elderly. Furthermore, there is a decreased production of albumin and plasma cholinesterase enzyme.
Changes in the Gastrointestinal System
Gastric emptying is prolonged and the gastric pH tends to rise. Age-related changes do not significantly alter anesthetic plan in these patients. Perioperative opioids, may however, aggravate constipation, which already has a higher incidence in the elderly.
Central Nervous System
Neurological complications are probably the most frequent complications seen in the elderly with postoperative delirium accounting for up to 53 % of the complications. Senile dementia, with an incidence up to 25 % at 85 years, is the strongest predictor of postoperative cognitive disorders. This indirectly adds to hidden morbidity in the elderly by increasing pulmonary complications (inability to cough/failing chest physiotherapy), inadequate analgesia (improper reporting, inability to use patient controlled analgesia), and failed early ambulation (increased incidence of deep vein thrombosis, muscle wasting).
The requirements of local and general anesthetics (minimum alveolar concentration-MAC) are reduced in the elderly. This is reflected by the decrease in cerebral blood flow, cerebral oxygen consumption, brain mass (30 % loss by 80 years of age), and decreased synthesis of neurotransmitters. Strong evidence exists in favor of multimodal analgesia in the elderly so as to decrease the use of long acting opioids. This may decrease the incidence of neurological complications in the elderly. Studies indicate the use of benzodiazepines to be associated with an increased incidence of delirium, and therefore, agents like dexmedetomidine are favorable for sedation purposes.
Pharmacology Changes in the Elderly
Pharmacokinetics
Biometric changes in body composition modify drug distributions in the elderly and cause changes in effect site concentrations. Lean muscle mass decreases by 40 %, with a decrease in the total body water. Subsequently, the volume of distribution of water-soluble drugs decreases, which increases the achieved effect site concentration. Conversely the proportion of body fat increases and, therefore, fat-soluble drugs undergo extensive redistribution, thereby, slowing their rate of elimination.
Centrally acting drugs may have a slower onset of action as a result of prolonged brain-arm circulation time. As hepatic and renal function decrease with age, drugs which are dependent on hepatic/renal clearance will have a prolonged duration of action. Lower serum albumin causes an increase in free plasma drug concentration, thus increasing the active form of the drug for the same dose. Initial boluses of drugs may need no dose modification (considering no change in drug sensitivity); however, subsequent doses need reduction or interval lengthening in view of slower elimination (Table 43.2).
Table 43.2
Effect of aging on pharmacology of common anesthesia drugs
Drug | Bolus/IV doses (for elderly >65 years) | Infusion | Adverse effects | Advantages | Comments |
---|---|---|---|---|---|
Sedatives and induction agents | |||||
Midazolam (sedation only) | 0.5 mg increments Age > 70—half dose Age > 90—quarter dose | Not recommended | Respiratory depression, rarely paradoxical reaction | Amnesia, anxiolysis, hemodynamic stability | Clearance same as in young, increased brain sensitivity |
Propofol | Sedation 0.5–0.8 mg/kg Induction 40–60 % reduced dose | 0.5–2 mg/kg/h (sedation) | Respiratory depression, hypotension | Rapid onset/offset, anti-emetic, clear headed recovery | Gradual doses cause less hypotension, decrease dose when used in combination with other drugs |
Dexmedetomidine (FDA approval for sedation only) | Sedation 0.5 mcg/kg (over 10 min) | Sedation 0.2–0.7 mcg/kg/min | Hypotension, sympatholysis, bradycardia | No respiratory depression, decreased cognitive dysfunction, analgesia, decreases IOP | No pharmacokinetic changes with age |
Etomidate (induction only) | 0.15–0.2 mg/kg | Not recommended | Respiratory and adrenal suppression, myoclonus | Minimal hypotension, short acting | Reports of single dose prolonged adrenal suppression in elderly |
Ketamine | Use lower dose ranges 1–4 mg/kg | Not recommended | Arrhythmia, hypertension, secretions | Minimal respiratory depression, no hypotension | Dissociative reactions, avoid in elderly |
Inhalation agents | |||||
Most preferred-sevoflurane and desflurane | MAC values decrease by 5 % each decade, elderly show 20–40 % lower MACs | Maintenance- 20–40 % MAC reduction | Hypotension, post operative residual effects, increased PONV | Duration-affected minimally with age as pulmonary excretion is unaffected with age | Use low solubility agent (sevoflurane/desflurane), slower uptake with age, age related VQ mismatch |
Opioids
Stay updated, free articles. Join our Telegram channelFull access? Get Clinical TreeGet Clinical Tree app for offline access |